Autologous adipose derived mesenchymal stem cells (mscs) clinical trials
Also written AdMSCs.
How each study uses autologous adipose derived mesenchymal stem cells (mscs) is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Keep track of what changes. Save the autologous adipose derived mesenchymal stem cells (mscs) studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesApprovals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2018 (2); 1 more planned to start later
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 7
Mayo Clinic (5) · Jacob L. Sellon, M.D. (1) · Celltex Therapeutics Corporation (1) · Yonsei University (1) · Kasiak Research Pvt. Ltd. (1)
Studies
Open first, then newest update. How each study uses autologous adipose derived mesenchymal stem cells (mscs) is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- Autologous Adipose-Derived Stem Cell Injections for Knee OsteoarthritisRecruitingNot applicableYonsei UniversityNCT07901790Written as Autologous Adipose-Derived Mesenchymal Stem Cells (ADMSCs)
- Adipose-Derived Mesenchymal Stem Cell for Preventing Biliary ComplicationsNot yet recruitingPhase 1Mayo ClinicNCT06649864Written as Autologous adipose derived mesenchymal stromal cells (AMSC)
- Autologous Adipose Tissue-Derived Mesenchymal Stem Cells (AdMSCs) for OsteoarthritisNot yet recruitingPhase 2Celltex Therapeutics CorporationNCT04448106Written as Celltex- AdMSCs
- Allogenic Adipose-derived Mesenchymal Stem Cells(AMSCs) for Epilepsy During Deep Brain Stimulation(DBS) SurgeryTerminatedEarly Phase 1Mayo ClinicNCT06280092Written as AMSCs
- Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)Active, not recruitingPhase 2Mayo ClinicNCT03268603Written as Autologous Adipose-derived Mesenchymal Stromal Cells
- Autologous Culture Expanded Adipose Derived MSCs for Treatment of Painful Hip OAActive, not recruitingPhase 1Mayo ClinicNCT03608579Written as Autologous Adipose Derived Mesenchymal Stromal Cells
- Autologous Culture Expanded Mesenchymal Stromal Cells for Knee OsteoarthritisCompletedPhase 1Jacob L. Sellon, M.D.NCT02805855Written as Autologous Adipose-Derived Mesenchymal Stromal Cells
- Autologous, Culture-Expanded Mesenchymal Stromal Cells for Degenerative Disc DiseaseTerminatedPhase 1Mayo ClinicNCT03461458Written as Autologous Adipose-Derived Mesenchymal Stromal Cells
- Evaluate Safety and Efficacy of Intravenous Autologous ADMSc for Treatment of Idiopathic Pulmonary FibrosisStatus unknownPhase 1/2Kasiak Research Pvt. Ltd.NCT02135380Written as Autologous Adipose Derived MSCs (ADMSCs)